Drug intelligence / Profile preview

Xuhanting

Development stage: Unknown
Lead developer: Guangzhou Baiyunshan Qixing Pharmaceutical
Administration: Oral

Overview

Xuhanting is a Traditional Chinese Medicine (TCM) formulation primarily used in pediatrics for the treatment of sweat syndrome (diaphoresis) and recurrent respiratory tract infections associated with Qi-Yin deficiency. The formulation is designed to tonify Qi, nourish Yin, and astringe sweat. Common ingredients in Xuhanting preparations include *Radix Astragali* (Huangqi), *Ostraea Gigas* (Muli), *Radix Oryzae Glutinosae* (Nuodaogen), *Fructus Jujubae* (Dazao), and *Radix et Rhizoma Ephedrae* (Mahuanggen). It is widely used in China to manage spontaneous and night sweating in children and has been the subject of multicenter prospective cohort studies to evaluate its efficacy in real-world medical environments.

Brand names: Xuhanting
Other names: Xuhanting GranulesXuhanting KeliXu Han Ting

Beyond the preview

Go deeper on Xuhanting.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xuhanting.

Explore the full profile